Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population

The prevalence of irritable bowel syndrome with constipation (IBS-C) is estimated to be between 4.3% and 5.2% among adults in the United States. Little is known about the health care resource utilization and costs associated with IBS-C. To (a) evaluate the annual total all-cause, gastrointestinal (G...

Ausführliche Beschreibung